After Covaxin and Covishield, now Pune-based drugmaker firm, Gennova Biopharmaceuticals is all set to start early to mid-stage human trials of its Covid-19 vaccine, HGCO19. The trials will start ‘’soon’’ and around 620 people will be enrolled for the vaccination programme in several cities in next few months.

Leave a Reply

Your email address will not be published. Required fields are marked *